bpc-157 human clinical trials evidence safety Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing Here's a nice graphic on
Description
No subscription or membership required
This was followed by a washout period where the compound was discontinued
(PubMed) Banka S, Ryan K, Thomson W, Newman WG
This occurred even though only 12.4% in the analysis had a B12 insufficiency (meaning they were at the borderline for a deficiency), and only 3% had a B12 deficiency
Lack of Human Data : While animal studies show positive effects, there's only one noteworthy human study on BPC-157, which raises questions about its efficacy and safety in humans 2
This distinction underscores the critical role of TCN2-Cbl as a biologically active form of Cbl [90]
